Zkusit zdarma
NuVasive, Inc.

NuVasive, Inc.

NUVA
Cena:
 
 
Valuace
0
Růst
30
Zdraví
69

Výsledky Q2 2023

Načítám obsah…
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.
It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment.
The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room.
preloader

Prezentace a earnings calls NuVasive, Inc. (NUVA)

DatumNázevKvartálRok
02.08.2023NUVA Q2 2023Q22023
10.05.2023NUVA Q1 2023Q12023
22.02.2023NUVA Q4 2022Q42022
09.02.2023NUVA Business Combination--
12.01.2023NUVA JPMorgan Healthcare Conference--
06.10.2022NUVA Investor Day 2022--
03.08.2022NUVA Q2 2022Q22022
04.05.2022NUVA Q1 2022Q12022
26.02.2018NUVA Q4 2017Q42017
24.10.2017NUVA Q3 2017Q32017